Clemens Lange
Clemens Lange
MD, PhD, FEBO, PD, Consultant, University Eye Hospital Freiburg
Verified email at uniklinik-freiburg.de - Homepage
Title
Cited by
Cited by
Year
Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT)
C Lange, N Feltgen, B Junker, K Schulze-Bonsel, M Bach
Graefe's Archive for Clinical and Experimental Ophthalmology 247 (1), 137-142, 2009
3092009
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
X Wang, S Abraham, JAG McKenzie, N Jeffs, M Swire, VB Tripathi, ...
Nature 499 (7458), 306-311, 2013
2822013
HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia
FM Mowat, UFO Luhmann, AJ Smith, C Lange, Y Duran, S Harten, ...
PloS one 5 (6), e11103, 2010
1002010
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
T Wecker, C Ehlken, A Bühler, C Lange, H Agostini, D Böhringer, A Stahl
British Journal of Ophthalmology 101 (3), 353-359, 2017
982017
Intraocular oxygen distribution in advanced proliferative diabetic retinopathy
CAK Lange, P Stavrakas, UFO Luhmann, DJ De Silva, RR Ali, ZJ Gregor, ...
American journal of ophthalmology 152 (3), 406-412. e3, 2011
802011
Expression of the COVID‐19 receptor ACE2 in the human conjunctiva
C Lange, J Wolf, C Auw‐Haedrich, A Schlecht, S Boneva, T Lapp, ...
Journal of medical virology 92 (10), 2081-2086, 2020
692020
Hsp90 inhibition protects against inherited retinal degeneration
M Aguila, D Bevilacqua, C McCulley, N Schwarz, D Athanasiou, ...
Human molecular genetics 23 (8), 2164-2175, 2014
622014
Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling
UFO Luhmann, CA Lange, S Robbie, PMG Munro, JA Cowing, HEJ Armer, ...
PLoS One 7 (4), e35551, 2012
622012
Pilot randomised controlled trial of face-down positioning following macular hole surgery
CAK Lange, L Membrey, N Ahmad, L Wickham, RE Maclaren, L Solebo, ...
Eye 26 (2), 272-277, 2012
612012
Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model
C Lange, C Ehlken, A Stahl, G Martin, L Hansen, HT Agostini
Graefe's Archive for Clinical and Experimental Ophthalmology 247 (9), 1205-1211, 2009
582009
Clinical experience with eplerenone to treat chronic central serous chorioretinopathy
B Cakir, F Fischer, C Ehlken, A Bühler, A Stahl, G Schlunck, D Böhringer, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 254 (11), 2151-2157, 2016
562016
Face‐down positioning or posturing after macular hole surgery
AL Solebo, CAK Lange, C Bunce, JW Bainbridge
Cochrane Database of Systematic Reviews, 2011
552011
Oxygen sensing in retinal health and disease
CAK Lange, JWB Bainbridge
Ophthalmologica 227 (3), 115-131, 2012
462012
Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy
FM Mowat, F Gonzalez, UFO Luhmann, CA Lange, Y Duran, AJ Smith, ...
The American journal of pathology 180 (4), 1726-1739, 2012
412012
VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation
A Fantin, A Lampropoulou, V Senatore, JT Brash, C Prahst, CA Lange, ...
Journal of Experimental Medicine 214 (4), 1049-1064, 2017
362017
Therapeutic interference with EphrinB2 signalling inhibits oxygen‐induced angioproliferative retinopathy
C Ehlken, G Martin, C Lange, EG Gogaki, U Fiedler, F Schaffner, ...
Acta ophthalmologica 89 (1), 82-90, 2011
352011
Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome
CA Lange, J Tisch-Rottensteiner, D Böhringer, G Martin, J Schwartzkopff, ...
Ophthalmology 119 (9), 1924-1929, 2012
342012
Apelin is required for non-neovascular remodeling in the retina
JAG McKenzie, M Fruttiger, S Abraham, CAK Lange, J Stone, P Gandhi, ...
The American journal of pathology 180 (1), 399-409, 2012
322012
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease
SJ Robbie, PL von Leithner, M Ju, CA Lange, AG King, P Adamson, ...
Investigative ophthalmology & visual science 54 (2), 1490-1500, 2013
312013
Myeloid-derived vascular endothelial growth factor and hypoxia-inducible factor are dispensable for ocular neovascularization—brief report
SE Liyanage, A Fantin, P Villacampa, CA Lange, L Denti, E Cristante, ...
Arteriosclerosis, thrombosis, and vascular biology 36 (1), 19-24, 2016
262016
The system can't perform the operation now. Try again later.
Articles 1–20